journal article·2023-09-20Open access

Recent Advances in Stem Cell Differentiation Control Using Drug Delivery Systems Based on Porous Functional Materials

Yun-Sik Eom, Joon-Ha Park, Tae-Hyung Kim

Abstract

The unique characteristics of stem cells, which include self-renewal and differentiation into specific cell types, have paved the way for the development of various biomedical applications such as stem cell therapy, disease modelling, and drug screening. The establishment of effective stem cell differentiation techniques is essential for the effective application of stem cells for various purposes. Ongoing research has sought to induce stem cell differentiation using diverse differentiation factors, including chemicals, proteins, and integrin expression. These differentiation factors play a pivotal role in a variety of applications. However, it is equally essential to acknowledge the potential hazards of uncontrolled differentiation. For example, uncontrolled differentiation can give rise to undesirable consequences, including cancerous mutations and stem cell death. Therefore, the development of innovative methods to control stem cell differentiation is crucial. In this review, we discuss recent research cases that have effectively utilised porous functional material-based drug delivery systems to regulate stem cell differentiation. Due to their unique substrate properties, drug delivery systems based on porous functional materials effectively induce stem cell differentiation through the steady release of differentiation factors. These ground-breaking techniques hold considerable promise for guiding and controlling the fate of stem cells for a wide range of biomedical applications, including stem cell therapy, disease modelling, and drug screening.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Integrative Engineering, Chung-Ang University, 84 Heukseuk-ro, Dongjak-gu, Seoul 06974, Republic of Korea

Funding

Chung-Ang University Research Scholarship Grants · the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)

References (100+)

Show source-provided references
2. Introduction to stem cell therapy10.1097/JCN.0b013e318197a6a5 ↗
3. Stem cells: Past, present, and future10.1186/s13287-019-1165-5 ↗
4. Stem cells in tissue engineering10.1038/35102181 ↗
5. Mahla, R.S. (2016). Stem Cells Applications in Regenerative Medicine and Disease Therapeutics. Int. J. Cell Biol., 2016.10.1155/2016/6940283 ↗
6. Skin tissue engineering: Wound healing based on stem-cell-based therapeutic strategies10.1186/s13287-019-1212-2 ↗
7. Stem cell-based regenerative medicine10.21037/sci.2019.06.04 ↗
8. Hematopoietic Stem-Cell Transplantation10.1056/NEJMra052638 ↗
9. Investigating human disease using stem cell models10.1038/nrg3764 ↗
10. 3D human induced pluripotent stem cell–derived bioengineered skeletal muscles for tissue, disease and therapy modeling10.1038/s41596-022-00790-8 ↗
11. Zhu, K., Bao, X., Wang, Y., Lu, T., and Zhang, L. (2023). Human induced pluripotent stem cell (hiPSC)-derived cardiomyocyte modelling of cardiovascular diseases for natural compound discovery. Biomed. Pharmacother., 157.10.1016/j.biopha.2022.113970 ↗
12. Opportunities and challenges of pluripotent stem cell neurodegenerative disease models10.1038/nn.3425 ↗
13. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell– and patient-derived tumor organoids10.1038/nm.3973 ↗
14. Using stem cell–derived neurons in drug screening for neurological diseases10.1016/j.neurobiolaging.2019.02.008 ↗
15. Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation10.1016/j.stem.2023.04.011 ↗
16. Regenerative therapy for neuronal diseases with transplantation of somatic stem cells10.4252/wjsc.v5.i4.163 ↗
17. Fibrinogen induces neural stem cell differentiation into astrocytes in the subventricular zone via BMP signaling10.1038/s41467-020-14466-y ↗
18. Advances in mesenchymal stem cell transplantation for the treatment of osteoporosis10.1111/cpr.12956 ↗
19. Epigenetic Regulation of Stem Cell Differentiation10.1203/01.pdr.0000203565.76028.2a ↗
20. The Role of Epigenetic in Dental and Oral Regenerative Medicine by Different Types of Dental Stem Cells: A Comprehensive Overview10.1155/2022/5304860 ↗
21. Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm10.1242/dev.02551 ↗
22. Characterizing the BMP pathway in a wild type mouse model of distraction osteogenesis10.1016/j.bone.2008.01.028 ↗
23. Wnt signaling and stem cell control10.1038/cr.2008.47 ↗
24. Osteosarcoma Development and Stem Cell Differentiation10.1007/s11999-008-0335-z ↗
25. LGR6 promotes osteogenesis by activating the Wnt/β-catenin signaling pathway10.1016/j.bbrc.2019.08.122 ↗
26. Amarasekara, D.S., Kim, S., and Rho, J. (2021). Regulation of Osteoblast Differentiation by Cytokine Networks. Int. J. Mol. Sci., 22.10.3390/ijms22062851 ↗
27. Recent advances on small molecules in osteogenic differentiation of stem cells and the underlying signaling pathways10.1186/s13287-022-03204-4 ↗
28. Signaling network regulating osteogenesis in mesenchymal stem cells10.1007/s12079-021-00635-1 ↗
29. Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function10.1111/j.1365-2362.1995.tb01532.x ↗
30. Effects of dexamethasone, ascorbic acid and β-glycerophosphate on the osteogenic differentiation of stem cells in vitro10.1186/scrt328 ↗
31. Growth differentiation factor 6 and transforming growth factor-beta differentially mediate mesenchymal stem cell differentiation, composition, and micromechanical properties of nucleus pulposus constructs10.1186/ar4505 ↗
32. Retinoic acid signaling and neuronal differentiation10.1007/s00018-014-1815-9 ↗
33. Role of Inflammatory Cytokines, Growth Factors and Adipokines in Adipogenesis and Insulin Resistance10.1007/s10753-021-01559-z ↗
34. Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation10.1634/stemcells.2006-0419 ↗
35. Integrin activation and internalization on soft ECM as a mechanism of induction of stem cell differentiation by ECM elasticity10.1073/pnas.1106467108 ↗
36. Tailored Integrin–Extracellular Matrix Interactions to Direct Human Mesenchymal Stem Cell Differentiation10.1089/scd.2011.0615 ↗
37. Stem cell differentiation is regulated by extracellular matrix mechanics10.1152/physiol.00026.2017 ↗
38. Epigenetic control of adult stem cell function10.1038/nrm.2016.76 ↗
39. Kang, M.-J., Cho, Y.-W., and Kim, T.-H. (2023). Progress in Nano-Biosensors for Non-Invasive Monitoring of Stem Cell Differentiation. Biosensors, 13.10.3390/bios13050501 ↗
40. Wnt signaling in cancer10.1038/onc.2016.304 ↗
41. The multiple usages of Notch signaling in development, cell differentiation and cancer10.1016/j.ceb.2018.06.010 ↗
42. Gordeeva, O. (2019). TGFβ Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells’ Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer. Cells, 8.10.3390/cells8121500 ↗
43. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells10.1038/nm.1982 ↗
44. Lamin A/C acts as an essential factor in mesenchymal stem cell differentiation through the regulation of the dynamics of the Wnt/β—Catenin pathway10.1002/jcb.25185 ↗
45. Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation10.2174/1574888X10666150723145707 ↗
46. Wnt signalling and its impact on development and cancer10.1038/nrc2389 ↗
47. WNT signalling pathways as therapeutic targets in cancer10.1038/nrc3419 ↗
48. The Wnt signaling pathway in cancer10.1016/j.critrevonc.2015.12.005 ↗
49. Wnt signaling and breast cancer10.4161/cbt.3.1.561 ↗
50. Wnt signaling in colorectal cancer: Pathogenic role and therapeutic target10.1186/s12943-022-01616-7 ↗
51. Retinoic Acid Metabolism and Inhibition of Cell Proliferation: An Unexpected Liaison
52. Multiple myeloma cells are protected against dexamethasone—Induced apoptosis by insulin-like growth factors10.1046/j.1365-2141.1997.592708.x ↗
53. Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis10.1074/jbc.M105318200 ↗
54. Glucocorticoid-induced osteoporosis: Pathophysiology and therapy10.1007/s00198-007-0394-0 ↗
55. The shift in the balance between osteoblastogenesis and adipogenesis of mesenchymal stem cells mediated by glucocorticoid receptor10.1186/s13287-019-1498-0 ↗
56. Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts10.1242/jcs.01572 ↗
57. Dexamethasone Enhances Oxidative Stress-Induced Cell Death in Murine Neural Stem Cells10.1007/s12640-012-9308-9 ↗
58. Induction of CYP26A1 by metabolites of retinoic acid: Evidence that CYP26A1 is an important enzyme in the elimination of active retinoids10.1124/mol.114.096784 ↗
59. Polymer Architecture and Drug Delivery10.1007/s11095-005-9046-2 ↗
60. The Smart Drug Delivery System and Its Clinical Potential10.7150/thno.14858 ↗
61. Developing micro-/nanoparticulate drug delivery systems using “design of experiments”10.4103/2230-973X.82395 ↗
62. Nanoparticles as drug delivery systems10.1016/S1734-1140(12)70901-5 ↗
63. Polymer-based nanocapsules for drug delivery10.1016/j.ijpharm.2009.10.018 ↗
64. Mesoporous silica nanoparticles in drug delivery and biomedical applications10.1016/j.nano.2014.09.014 ↗
65. Trojan particles: Large porous carriers of nanoparticles for drug delivery10.1073/pnas.182233999 ↗
66. Preparation and characterization of porous hollow silica nanoparticles for drug delivery application10.1016/S0142-9612(03)00566-0 ↗
67. The role of porous media in biomedical engineering as related to magnetic resonance imaging and drug delivery10.1007/s00231-006-0142-6 ↗
68. Porous silicon in drug delivery devices and materials10.1016/j.addr.2008.03.017 ↗
69. Flexible Porous Metal-Organic Frameworks for a Controlled Drug Delivery10.1021/ja710973k ↗
70. Porous carriers for controlled/modulated drug delivery10.4103/0250-474X.59540 ↗
71. Drug delivery from structured porous inorganic materials10.1002/wnan.132 ↗
72. Porous silica microshells from diatoms as biocarrier for drug delivery applications10.1016/j.powtec.2011.04.023 ↗
73. Porous metal–organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
74. Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery10.1021/cm402592t ↗
75. Mesoporous Silica Nanoparticles for Protein Protection and Delivery10.3389/fchem.2019.00290 ↗
76. Smart drug delivery: Capping strategies for mesoporous silica nanoparticles10.1016/j.micromeso.2020.110115 ↗
77. Application of MOF materials as drug delivery systems for cancer therapy and dermal treatment10.1016/j.ccr.2021.214262 ↗
78. Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier10.1016/j.jddst.2022.103729 ↗
79. Controlled Intracellular Release of Doxorubicin in Multidrug-Resistant Cancer Cells by Tuning the Shell-Pore Sizes of Mesoporous Silica Nanoparticles10.1021/nn2033105 ↗
80. Size Control of Porous Silicon Nanoparticles by Electrochemical Perforation Etching10.1002/ppsc.201300244 ↗
81. Pore size control in the synthesis of hydroxyapatite nanoparticles: The effect of pore expander content and the synthesis temperature10.1016/j.ceramint.2016.04.041 ↗
82. Size control over metal–organic framework porous nanocrystals10.1039/C9SC03802G ↗
83. Evaluation of mammalian cell adhesion on surface-modified porous silicon10.1016/j.biomaterials.2006.04.015 ↗
84. Osteoblast-like cell adhesion on porous silicon-incorporated TiO2 coating prepared by micro-arc oxidation10.1002/jbm.b.31804 ↗
85. Self-assembled Biodegradable Nanoparticles and Polysaccharides as Biomimetic ECM Nanostructures for the Synergistic effect of RGD and BMP-2 on Bone Formation10.1038/srep25090 ↗
86. Mesoporous Silica Nanoparticles-Reinforced Hydrogel Scaffold together with Pinacidil Loading to Improve Stem Cell Adhesion10.1002/cnma.201800026 ↗
87. Guiding mesenchymal stem cell differentiation using mesoporous silica nanoparticle-based films10.1016/j.actbio.2019.07.008 ↗
88. Biodegradable Mesoporous Silica Nanocarrier Bearing Angiogenic QK Peptide and Dexamethasone for Accelerating Angiogenesis in Bone Regeneration10.1021/acsbiomaterials.9b01521 ↗
89. Incorporation of dexamethasone-loaded mesoporous silica nanoparticles into mineralized porous biocomposite scaffolds for improving osteogenic activity10.1016/j.ijbiomac.2020.01.237 ↗
90. Novel nanocomposite scaffold based on gelatin/PLGA-PEG-PLGA hydrogels embedded with TGF-β1 for chondrogenic differentiation of human dental pulp stem cells in vitro10.1016/j.ijbiomac.2021.12.097 ↗
91. Choe, G., Lee, M., Oh, S., Seok, J.M., Kim, J., Im, S., Park, S.A., and Lee, J.Y. (2022). Three-dimensional bioprinting of mesenchymal stem cells using an osteoinductive bioink containing alginate and BMP-2-loaded PLGA nanoparticles for bone tissue engineering. Biomater. Adv., 136.10.1016/j.bioadv.2022.212789 ↗
92. Nanohybrid biodegradable scaffolds for TGF-β3 release for the chondrogenic differentiation of human mesenchymal stem cells10.1016/j.ijpharm.2020.119248 ↗
93. Single metal-organic framework–Embedded nanopit arrays: A new way to control neural stem cell differentiation10.1126/sciadv.abj7736 ↗
94. Biomimetic Metal-Organic Frameworks as Targeted Vehicles to Enhance Osteogenesis10.1002/adhm.202102821 ↗
95. Yu, D., Ma, M., Liu, Z., Pi, Z., Du, X., Ren, J., and Qu, X. (2020). MOF-encapsulated nanozyme enhanced siRNA combo: Control neural stem cell differentiation and ameliorate cognitive impairments in Alzheimer’s disease model. Biomaterials, 255.10.1016/j.biomaterials.2020.120160 ↗
96. Jia, Y., Zhang, P., Sun, Y., Kang, Q., Xu, J., Zhang, C., and Chai, Y. (2019). Regeneration of large bone defects using mesoporous silica coated magnetic nanoparticles during distraction osteogenesis. Nanomed. Nanotechnol. Biol. Med., 21.10.1016/j.nano.2019.102040 ↗
97. 3D-printed platform multi-loaded with bioactive, magnetic nanoparticles and an antibiotic for re-growing bone tissue10.1016/j.ijpharm.2020.120097 ↗
98. Graphene Oxide-loaded magnetic nanoparticles within 3D hydrogel form High-performance scaffolds for bone regeneration and tumour treatment10.1016/j.compositesa.2021.106672 ↗
99. Near-Infrared Light-Controlled and Real-Time Detection of Osteogenic Differentiation in Mesenchymal Stem Cells by Upconversion Nanoparticles for Osteoporosis Therapy10.1021/acsnano.2c02900 ↗
100. Photocontrolled chondrogenic differentiation and long-term tracking of mesenchymal stem cells in vivo by upconversion nanoparticles10.1039/D1TB02074A ↗